UK ups the ante on antibiotics

24 January 2019
uk_london-1-

Strongly-worded rhetoric around the dangers posed by antibiotic resistance (AMR) is nothing new, but even by these standards, the UK government has laid bare how seriously it regards this issue.

Health Secretary Matt Hancock spoke in uncompromising terms at the World Economic Forum to unveil the UK’s five-year plan and 20-year vision for containing and controlling AMR.

"AMR is as big a danger to humanity as climate change or warfare"

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical